HCPLive
The 2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Fifth Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is “unique in bringing together all groups committed to improving the lives of people with MS,” and will provide “state-of-the-art information on the latest treatments, research, models of care, epidemiology, genetics, and much more.”
2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers

2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers | CMSC 2013

Conference Coverages

Clinical Outcome Measures and Future Directions for Multiple Sclerosis Care Centers
Clinical Outcome Measures and Future Directions for Multiple Sclerosis Care Centers
To prepare for coming changes at the CMS driven by the Affordable care Act, multiple sclerosis care centers should begin to develop MS-specific electronic health record templates that record clinical outcome measures.
A Patient-Centered Medical Home Model for Measuring Multiple Sclerosis Outcomes
With so many different interdependent symptoms affecting MS pathogenesis, effective treatment requires intervention by a multidisciplinary team, with progress assessed by validated instruments that measure variables such as physical health, psychological health, and social relationships.
Cognitive Rehabilitation for Improving Everyday Life in Patients with Multiple Sclerosis
Experimental data suggest that memory-retraining exercises and other cognitive rehabilitation techniques may improve memory acquisition and retention in patients with multiple sclerosis.
The Challenge of Managing Pain in Multiple Sclerosis
Pain is a common symptom in patients with multiple sclerosis (MS), with some studies showing that clinically significant pain associated with their disease is experienced by more than half of patients with MS.
Integrating Behavioral Medicine into Effective Treatment of Multiple Sclerosis
Comprehensive care for patients with MS starts with medical treatment of the symptoms of their disease, but must also include intervention by clinicians who can address the mental, physical, and social challenges experienced by many patients.
The Evolution of the Diagnostic Process in Multiple Sclerosis
Early diagnosis is one of the most important characteristics of effective MS treatment, since the greatest irreversible disabilities tend to occur early in the course of MS disease progression.
Treating Progressive Multiple Sclerosis with Various Disease-Modifying Therapies
Physicians must consider a range of factors when initiating treatment with disease-modifying drug therapy and be prepared to switch to another first- or second-line option if the patient fails to respond.

Most Popular

$vacMongoViewPlus$ $vAR$